Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00169195
Status:
COMPLETED
Last Update Posted:
2015-09-02
First Post:
2005-09-12
Brief Title:
Rituximab Gemcitabine and Oxaliplatin R-GEMOX for RefractoryRelapsed B-cell Lymphoma
Sponsor:
Organization:
Lymphoma Study Association